Recurrent Seizures in Tramadol Intoxication: Implications for Therapy Based on 100 Patients

Basic and Clinical Pharmacology and Toxicology

Volumn 111, Issue 2, 2012, Pages 133-136

  Shadnia, Shahin ^a   Brent, Jeffrey ^a   Mousavi Fatemi, Khatereh ^b   Hafezi, Peyman ^b   Soltaninejad, Kambiz ^c  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; CLONAZEPAM; DIAZEPAM; LORAZEPAM; MIDAZOLAM; NALTREXONE; PARACETAMOL; TRAMADOL;

ADULT; ANAMNESIS; ANTICONVULSANT THERAPY; ARTICLE; BREATHING RATE; COMA; CONSCIOUSNESS LEVEL; DIASTOLIC BLOOD PRESSURE; DRUG INTOXICATION; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPHYLAXIS; PULSE RATE; RECURRENT DISEASE; RETROSPECTIVE STUDY; SEIZURE; SYSTOLIC BLOOD PRESSURE; VITAL SIGN;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANALGESICS, OPIOID; ANTICONVULSANTS; CHILD; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PRESCRIPTION DRUG MISUSE; RETROSPECTIVE STUDIES; SEIZURES; TRAMADOL; YOUNG ADULT;

EID: 84864020648     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2012.00874.x     Document Type: Article

References (28)

1. Shipton EA. Tramadol-present and future. Anaesth Intensive Care 2000;28:363-74.
2. Grond S, Sablotzki A. Clinical pharmacology of tramadol. Clin Pharmacokinet 2004;43:879-923.
3. Gholami K, Shalviri G, Zarbakhsh A, Daryabari N, Yousefian S. New guideline for tramadol usage following adverse drug reactions reported to the Iranian pharmacovigilance center. Pharmacoepidemiol Drug Saf 2007;16:229-37.
4. Manocha A, Sharma KK, Mediratta PK. On the mechanism of anticonvulsant effect of tramadol in mice. Pharmacol Biochem Behav 2005;82:74-81.
5. Raffa RB, Friderichs E, Reimann W, Shank RP, Codd EE, Vaught JL. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an "atypical" opioid analgesic. J Pharmacol Exp Ther 1992;260:275-85.
6. Scott LJ, Perry CM. Tramadol: a review of its use in perioperative pain. Drugs 2000;60:139-76.
7. Shadnia S, Soltaninejad K, Heydari K, Sasanian G, Abdollahi M. Tramadol intoxication: a review of 114 cases. Hum Exp Toxicol 2008;27:201-5.
8. Hahn IH, Nelson LS. Opioids. In Brent J, Wallace KL, Burkhart KK, Phillips SD, Donovan JW (eds). Critical Care Toxicology: Diagnosis and Management of the Critically Poisoned Patient. Elsevier Mosby, Philadelphia, PA, 2005;611-9.
9. Spiller HA, Gorman SE, Villalobos D, Benson BE, Ruskosky DR, Stancavage MM et al. Prospective multicenter evaluation of tramadol exposure. J Toxicol Clin Toxicol 1997;35:361-4.
10. Talaie H, Panahandeh R, Fayaznouri MR, Asadi Z, Abdollahi M. Dose-independent occurrence of seizure with tramadol. J Med Toxicol 2009;5:63-7.
11. Jovanović-Čupić V, Martinović Z, Nešić N. Seizures associated with intoxication and abuse of tramadol. Clin Toxicol 2006;44:143-6.
12. Clarot F, Goulle JP, Vaz E, Proust B. Fatal overdoses of tramadol: is benzodiazepine a risk factor of lethality? Forensic Sci Int 2003;134:57-61.
13. Clarot F, Proust B, Vaz E, Goulle JP. Tramadol-benzodiazepines and buprenorphine-benzodiazepines: two potentially fatal cocktails? J Clin Forensic Med 2003;10:125-8.
14. Musshoff F, Madea B. Fatality due to ingestion of tramadol alone. Forensic Sci Int 2001;116:197-9.
15. McCarron MM, Schulze BW, Walberg CB, Thompson GA, Ansari A. Short-acting barbiturate overdosage. Correlation of intoxication score with serum barbiturate. JAMA 1982;248:55-61.
16. Shadnia S, Esmaily H, Sasanian G, Pajoomand A, Hassanian-Moghaddam H, Abdollahi M. Pattern of acute poisoning in Tehran - Iran in 2003. Hum Exp Toxicol 2007;26:753-6.
17. Soleymani F, Shalviri G, Abdollahi M. Pattern of use and adverse drug reactions of tramadol; a review of 336, 610, 664 insured prescriptions during 5 years. Int J Pharmacol 2011;7:757-60.
18. Marquardt KA, Alsop JA, Albertson TE. Tramadol exposures reported to statewide poison control system. Ann Pharmacother 2005;39:1039-44.
19. Gobbi M, Mennini T. Release studies with rat brain cortical synaptosomes indicate that tramadol is a 5-hydroxytryptamine uptake blocker and not a 5-hydroxytryptamine release. Eur J Pharmacol 1999;370:23-6.
20. Oliva P, Aurilo C, Massimo F, Grella A, Maione S, Grella E. The antinociceptive effect of tramadol in the formalin test is mediated by the serotonergic component. Eur J Pharmacol 2002;445:179-85.
21. Roth BL, Baner K, Westkaemper R et al. Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist. Proc Natl Acad Sci USA 2002;99:11934-9.
22. Taghaddosinejad F, Mehrpour O, Afshari R, Seghatoleslami A, Abdollahi M, Dart RC. Factors related to seizure in tramadol poisoning and its blood concentration. J Med Toxicol 2011;7:183-8.
23. Decker KD, Cordonnier J, Jacobs W, Coucke V, Schepens P, Jorens PG. Fatal intoxication due to tramadol alone: case report and review of the literature. Forensic Sci Int 2008;175:79-82.
24. Michaud K, Augsburger M, Romain N, Giroud C, Mangin P. Fatal overdose of tramadol and alprazolam. Forensic Sci Int 1999;105:185-9.
25. Wallace KL. Toxin-induced seizures. In Brent J, Wallace KL, Burkhart KK, Phillips SD, Donovan JW (eds). Critical Care Toxicology: Diagnosis and Management of the Critically Poisoned Patient. Elsevier Mosby, Philadelphia, PA, 2005;225-39.
26. Rang HP, Dale MM, Ritter JM, Moore PK. Antiepileptic drugs. In: Rang HP, Dale MM, Ritter JM, Moore PK (eds.). Pharmacology, 5th edn. Churchill Livingstone, Edinburgh, 2003;550-61.
27. Rogawski MA, Porter RJ. Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds. Pharmacol Rev 1990;42:223-86.
28. Shah ASV, Eddelston M. Should phenytoin or barbiturates be used as second-line anticonvulsant therapy for toxicological seizures? Clin Toxicol 2010;48:800-5.